Navigation Links
Takeda to Acquire Nycomed
Date:5/18/2011

xpectations. We are proud to have contributed to Nycomed's development into a world-class pharmaceutical company with a strong market position and product pipeline. I feel confident that Takeda will be able to further build upon Nycomed's potential and create an even stronger company with a global market presence," said Kristoffer Melinder, Managing Partner of NC Advisory AB, advisor to the Nordic Capital funds.

1.  Expected benefits

  • Strong fit with Takeda’s sustainable growth strategy
  • Strengthens pan-European platform
  • Leverages Nycomed’s emerging markets strength to drive growth
  • Allows Takeda to maximize the value of its portfolio supported by enhanced development expertise and commercialization capability in Europe and emerging markets
  • Provides a significant growth driver with roflumilast (Daxas® tradename in Europe)
  • Immediate financial contribution(*)
  • More than 30% increase of annual revenue
  • More than 40% increase of operating income (excluding special factors derived from business acquisition)
  • More than 30% increase of EPS (excluding special factors derived from business acquisition)

  • (*) Comparison with the original outlook of fiscal 2013 in 2011-2013 Mid-Range Plan, announced on May 11, 2011

  • Complementary cultures and diverse talent pool

  • 2.  Acquisition summary (1)

    Acquiring company: Takeda Pharmaceutical Company Limited(2)

    Shareholders of Nycomed include Nordic Capital Funds V and VI, DLJ Merchant Banking Partners (a Credit Suisse affiliate), Coller International Partners IV and V, and Avista Capital Partners, Nycomed’s management and employees team(3)

    Number of outstanding shares: 13,778,110 shares (as of December 31, 2010)(4)

    Payment: Cash (Takeda will finance part of the transaction through a loan for about 600 to 700 billion yen)(5)

    Acquisition amount: &
    '/>"/>

    SOURCE Takeda Pharmaceutical Company Limited
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S.
    2. Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia
    3. Takeda Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
    4. Takedas Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed
    5. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
    6. Takeda Initiates Two Phase III Studies with Vedolizumab (MLN0002) in Patients with Inflammatory Bowel Disease
    7. Takeda to Revise Timing of Alogliptin and Alogliptin/ACTOS MAA Filings in Europe
    8. Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes
    9. Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl)
    10. Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin, An Investigational Treatment for Type 2 Diabetes
    11. Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/28/2015)... 2015 Baebies, Inc. today announced the completion ... The oversubscribed round of financing included key investors Rex ... Cunning Capital, Triad, LLC, the Duke Angel Network and ... of Advanced Liquid Logic,s (ALL) former investors including Charleston ... "Rex is pleased to support this promising ...
    (Date:7/28/2015)...  CryoLife, Inc. (NYSE: CRY ), a leading ... and vascular surgery, announced today its results for the ... Pat Mackin, Chairman, President and Chief Executive ... on our growth strategy with solid progress on several ... plans to transition to a direct sales model in ...
    (Date:7/28/2015)... , July 28, 2015 Voalte, the ... global leader in purpose-built wireless communications, today announced ... Regional), a 104-bed acute-care facility in ... the Voalte One™ solution on Spectralink PIVOT™ purpose-built ... Spectralink named Voalte a member of its AIMS ...
    Breaking Medicine Technology:Baebies, Inc. Raises $13 Million in Oversubscribed Round of Financing 2CryoLife Reports Second Quarter Financial Results 2CryoLife Reports Second Quarter Financial Results 3CryoLife Reports Second Quarter Financial Results 4CryoLife Reports Second Quarter Financial Results 5CryoLife Reports Second Quarter Financial Results 6CryoLife Reports Second Quarter Financial Results 7CryoLife Reports Second Quarter Financial Results 8CryoLife Reports Second Quarter Financial Results 9CryoLife Reports Second Quarter Financial Results 10CryoLife Reports Second Quarter Financial Results 11CryoLife Reports Second Quarter Financial Results 12CryoLife Reports Second Quarter Financial Results 13CryoLife Reports Second Quarter Financial Results 14Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 2Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 3
    ... June 14, 2011 Theramed Corporation ("Theramed") ... the 67th Clinical Meeting of the Society of Obstetricians ... devices are to be used to advance the practice ... device products have been approved for sale by Health ...
    ... MARINO, Calif., June 14, 2011 Viral Genetics, ... to a clinical-stage company. The Company,s two lead ... Metabolic Disruption (MDT) compounds for drug-resistant cancers -- ... or investigator-initiated Investigational New Drug (IND) pathways. An ...
    Cached Medicine Technology:Theramed Corporation to Launch Glenveigh Products, ebb™ and jetty™ at the Society of Obstetricians and Gynecologists of Canada 2Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs 2Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs 3Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs 4
    (Date:7/28/2015)... ... 28, 2015 , ... Every July, since 2007, about 25 pediatric pulmonary hypertension ... movies and television. They go to summer camp. , PH is incurable and life ... as it pushes hard to get blood through arteries in the lungs narrowed by ...
    (Date:7/28/2015)... ... July 28, 2015 , ... A skin cancer screening program ... 2015 Power of A award for “helping to make the world a better place.” ... Award winner by the American Society of Association Executives. Power of A recognizes organizations ...
    (Date:7/28/2015)... ... 28, 2015 , ... World Patent Marketing, a vertically integrated ... that makes shelling eggs an exact science. , “The global kitchen appliances market ... Creative Director of World Patent Marketing. “With a growth rate of 6.4%, market ...
    (Date:7/28/2015)... ... July 28, 2015 , ... By 2016, the number ... ability to engage with customers on a highly personal basis, increasing customer loyalty. However, ... on big growth opportunities or lose customers to more nimble competitors. , The Open ...
    (Date:7/28/2015)... ... July 28, 2015 , ... DuPont leaders today ... Ethiopia to learn more about the impact of U.S. collaborations with local partners ... on accelerating agricultural development as an engine of broad-based economic growth in the ...
    Breaking Medicine News(10 mins):Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 3Health News:ASDS Skin Cancer Program Honored 2Health News:ASDS Skin Cancer Program Honored 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 2Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 4Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 5Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 2Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4
    ... part in therapy , , TUESDAY, Sept. 4 (HealthDay News) -- ... teens with bulimia, a new study has found. , When ... teens able to abstain from the eating disorder,s binge-purge pattern ... as part of the problem, rather than part of the ...
    ... for annual preventive exams for adolescents, only 10 percent of ... recommended three shots needed for HPV vaccine. Ideally the three ... of teens see their physicians that often. , In ... three shots before they are exposed to the virus, said ...
    ... who are treated by primary care physicians do not ... new RAND Corporation study. , Physicians had high rates ... measures of quality that researchers examined and had low ... recommendations studied, according to the report in the September ...
    ... a long-acting growth hormone for use in human therapy. ... with growth hormone disorders will not have to have ... , Most hormones and cytokines have a short ... the new technology developed by the multidisciplinary team at ...
    ... of 5 who receive an annual flu shot have a ... be admitted to the hospital because of flu-related illness. ... analyzes how many outpatient visits or hospitalizations might be prevented ... children could eliminate as many as 650,000 doctors office visits ...
    ... 4 inVentiv Health, Inc.,(Nasdaq: VTIV ) ... Officer, and David Bassin, Chief Financial Officer, will ... Healthcare Conference taking,place at The Grand Hyatt in ... companies spanning all sectors of healthcare, with management,presentations ...
    Cached Medicine News:Health News:Parental Involvement Key to Battling Bulima 2Health News:Parental Involvement Key to Battling Bulima 3Health News:Teens need to see their doctors more often 2Health News:Study finds primary care depression treatment often does not follow quality guidelines 2Health News:Study finds primary care depression treatment often does not follow quality guidelines 3Health News:Researchers develop long-lasting growth hormone 2Health News:Annual flu shot cuts need for doctors' visits, hospitalization among children 2Health News:inVentiv Health to Present at the 20th Annual Bear Stearns Healthcare Conference 2
    ... Multichannel Pipettor The Equalizer replaces ... with an industry breakthroughequal tip spacings that ... slide rod. This innovation allows the quick ... with different configurations. Adjustable and Equal ...
    ... Unparalleled Comfort Pick one of our pipettors ... the trigger and ejector positionsright where they should ... are ergonomically designed to help avoid repetitive stress ... Productivity In The Palm Of Your Hand ...
    ... Design for Unparalleled Comfort Pick one of ... balance. Notice the trigger and ejector positionsright where ... our pipettors are ergonomically designed to help avoid ... pipetting. Productivity In The Palm Of Your ...
    ... Pick one of our pipettors up and ... and ejector positionsright where they should beeven if ... designed to help avoid repetitive stress injuries caused ... The Palm Of Your Hand Start dispensing ...
    Medicine Products: